In vivo characterization of a selective FGFR2 inhibitor with potency against gatekeeper and molecular brake mutations

被引：0
|
作者：
Fischer, John
Bouhana, Karyn
Chicarelli, Mark
Fell, Brad
Fulton, Jennifer
Guarnieri, Anna
Haygood, Leyla
Jalluri, Ravi
Johnson, Amber
Mclean, Brent
Mejia, Max
Rieger, Rob
Robinson, John
Rodriguez, Mareli
Sullivan, Francis
Wang, Yang
Winski, Shannon
Zhou, YeYun
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-1439
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1439
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Evidence for selective advantage of pathogenic FGFR2 mutations in the male germ line
    Goriely, A
    McVean, GAT
    Röjmyr, M
    Ingemarsson, B
    Wilkie, AOM
    SCIENCE, 2003, 301 (5633) : 643 - 646
  • [22] Computational Insights into the Resistance of the Gatekeeper Mutation V564F of FGFR2 Against Pemigatinib
    Liu, Jiayu
    Jin, Qi
    Xia, Jingying
    Liu, Ling
    Liu, Yuee
    Jiang, Lei
    JOURNAL OF COMPUTATIONAL BIOPHYSICS AND CHEMISTRY, 2024, 23 (07): : 891 - 900
  • [23] Functional characterization of FGFR2 mutations in melanoma reveals multiple mechanisms of inactivation
    Gartside, Michael G.
    Bengston, Ana
    Ibrahimi, Omar
    Curtis, Amy
    Yudt, Laura
    Mann, Graham
    Bastian, Boris
    Meltzer, Paul
    Mohammadi, Moosa
    Pollock, Pamela
    CANCER RESEARCH, 2006, 66 (08)
  • [24] Characterization of FGFR1, FGFR2 and FGFR3 mutations in 45 Brazilian patients with craniosynostosis.
    Passos-Bueno, MR
    Sertié, AL
    Richieri-Costa, A
    Alonso, LG
    Zatz, M
    Alonson, N
    Brunoni, D
    Ribeiro, SFM
    Cavalheiro, S
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A342 - A342
  • [25] FGFR2 Gene Amplification in Gastric Cancer Predicts Sensitivity to the Selective FGFR Inhibitor AZD4547
    Xie, Liang
    Su, Xinying
    Zhang, Lin
    Yin, Xiaolu
    Tang, Lili
    Zhang, Xiuhua
    Xu, Yanping
    Gao, Zeren
    Liu, Kunji
    Zhou, Minhua
    Gao, Beirong
    Shen, Danping
    Zhang, Lianhai
    Ji, Jiafu
    Gavine, Paul R.
    Zhang, Jingchuan
    Kilgour, Elaine
    Zhang, Xiaolin
    Ji, Qunsheng
    CLINICAL CANCER RESEARCH, 2013, 19 (09) : 2572 - 2583
  • [26] From Fragment to Lead: De Novo Design and Development toward a Selective FGFR2 Inhibitor
    Turner, Lewis D.
    Trinh, Chi H.
    Hubball, Ryan A.
    Orritt, Kyle M.
    Lin, Chi-Chuan
    Burns, Julie E.
    Knowles, Margaret A.
    Fishwick, Colin W. G.
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (02) : 1481 - 1504
  • [27] Identifying FGFR2 fusions/rearrangements in cholangiocarcinoma patients using a novel cfDNA algorithm for treatment with RLY-4008, a highly selective irreversible FGFR2 inhibitor
    Schram, A.
    Borad, M.
    Sahai, V.
    Kamath, S.
    Kim, R.
    Liao, C. Y. A.
    Oh, D. Y.
    Ponz-Sarvise, M.
    Yachnin, J.
    Shell, S. A.
    Cassier, P.
    Dotan, E.
    Florou, V.
    Moreno, V.
    Park, J. O.
    Tai, D.
    Schmidt-Kittler, O.
    Ferte, C.
    Goyal, L.
    Subbiah, V.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S116 - S116
  • [28] Discovery and preclinical characterization of ISM8001, a covalent and selective FGFR2/FGFR3 dual inhibitor with strong monotherapy anti-tumor activity against advanced solid tumors
    Zhang, Yihong
    Wang, Yazhou
    Cai, Xin
    Liu, Jinxin
    Cui, Hui
    Qiao, Junwen
    Lin, Xiaoxia
    Ding, Xiao
    Bavadekar, Supriya
    Rao, Sujata
    Zhang, Man
    Ren, Feng
    Zhavoronkov, Alex
    CANCER RESEARCH, 2024, 84 (06)
  • [29] Description of a new mutation and characterization of FGFR1, FGFR2, and FGFR3 mutations among Brazilian patients with syndromic craniosynostoses
    Passos-Bueno, MR
    Sertié, AL
    Richieri-Costa, A
    Alonso, LG
    Zatz, M
    Alonso, N
    Brunoni, D
    Ribeiro, SFM
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1998, 78 (03): : 237 - 241
  • [30] Discovery of LHQ490 as a highly selective fibroblast growth factor receptor 2 (FGFR2) inhibitor
    Li, Huiqiong
    Ke, Ran
    Zhou, Yang
    Chang, Shaohua
    Wang, Jie
    Su, Chen
    Wu, Pinglian
    Yang, Bowen
    Wang, Zhen
    Ding, Ke
    Ma, Dawei
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 272
12345